Frontlight ResearchEarly access
Huntington's disease trials in United States
9 of 21 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleStudy to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease
- Where
- Boston, Charlestown, Columbus, Englewood
- Age
- 25 years and over
- People
- 400 worldwide
- Run by
- Skyhawk Therapeutics, Inc.
See details and how to joinNCT07378644 · EU 2025-522263-14-00 - Phase 3Taking peoplePridopidine Phase 3 Study in Huntington's Disease
- Where
- Baltimore, Birmingham, Boca Raton, Burlington, Charlestown, Chicago, Cincinnati, Cleveland, Columbus, Durham, Gainesville, Golden Valley, Houston, Kansas City, Kirkland, La Jolla, Los Angeles, Nashville, New York, Portland, Sacramento, Seattle, Washington D.C., Wichita
- Age
- 23 years to 65 years
- People
- 400 worldwide
- Run by
- Prilenia
See details and how to joinNCT07609108 · EU 2026-526093-16-00 - No phaseTaking peopleFeasibility and Acceptability of an LLM-based Chatbot for Family Caregivers: Evaluation Study
- Where
- Ann Arbor
- Age
- 18 years and over
- People
- 60
- Run by
- University of Michigan
See details and how to joinNCT07280650 - Phase 3Taking peopleA Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
- Where
- Albany, Atlanta, Baltimore, Birmingham, Boston, Buffalo, Burlington, Chapel Hill, Chicago, Cleveland, Detroit, Durham, Englewood, Fairway, Farmington, Georgetown, Grand Rapids, Houston, Indianapolis, Iowa City, La Jolla, Little Rock, Madison, Memphis, Miami, Nashville, New York, Philadelphia, Pittsburgh, Portland, Richmond, Rochester, Sacramento, San Francisco, Seattle, Stanford, Tampa, Washington D.C., Wichita
- Age
- 21 years to 70 years
- People
- 770 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07326709 · EU 2025-522227-99-00 - Phase 1/2Taking peopleA Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease
- Where
- Boston, Cincinnati, Columbus, Philadelphia, Pittsburgh
- Age
- 25 years to 65 years
- People
- 53
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06826612 - Phase 1/2Taking peopleSafety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease
- Where
- Irvine
- Age
- 18 years to 65 years
- People
- 21
- Run by
- Leslie Thompson
See details and how to joinNCT07451613 - No phaseTaking peopleHome-based Transcranial Direct Current Stimulation Open Trial for Behavioral and Cognitive Symptoms in Huntington's Disease
- Where
- Houston
- Age
- 18 years to 80 years
- People
- 10
- Run by
- The University of Texas Health Science Center, Houston
See details and how to joinNCT05326451 - No phaseTaking peopleHome-based TDCS (Transcranial Direct Current Stimulation) for Cognitive and Behavioral Symptoms in Huntington's Disease
- Where
- San Antonio
- Age
- 18 years to 85 years
- People
- 16
- Run by
- The University of Texas Health Science Center at San Antonio
See details and how to joinNCT06843252 - No phaseTaking peopleSocial Cognition Training in Individuals With Huntington's Disease
- Where
- Chicago
- Age
- 18 years to 65 years
- People
- 20
- Run by
- Rush University Medical Center
See details and how to joinNCT06828471